Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Syndax revenue
Syndax's revenue is $23.7 million.
What is Syndax's revenue?
- Syndax's revenue growth from 2015 to 2024 is 3,676.71%.
- Syndax has 61 employees, and the revenue per employee ratio is $388,196.
- Syndax's peak quarterly revenue was $126.6M in 2021(q4).
- Syndax peak revenue was $139.7M in 2021.
- Syndax annual revenue for 2021 was 139.7M, 9,109.56% growth from 2020.
- Syndax annual revenue for 2024 was 23.7M, -83.05% growth from 2021.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Syndax historical revenue
Syndax's peak revenue was $139.7M in 2021. The peak quarterly revenue was $126.6M in 2021(q4).
Syndax's revenue increased from $627.0k in 2015 to $23.7M currently. That's a 3,676.71% change in annual revenue.
Syndax annual revenue
Syndax annual revenue over time
| Fiscal year / year | Syndax revenue |
|---|---|
| 2015 | $627,000 |
| 2016 | $1.2M |
| 2017 | $2.1M |
| 2018 | $1.5M |
| 2019 | $1.5M |
| 2020 | $1.5M |
| 2021 | $139.7M |
| 2024 | $23.7M |
How accurately did Syndax's revenue projections match actual performance?
Syndax annual growth
Syndax saw the greatest revenue growth in 2021, when revenue increased by 9,109.56%.
Syndax had the lowest revenue growth in 2018, when revenue changed by -28.04%.
Syndax annual growth rate over time
| Year | Syndax growth |
|---|---|
| 2016 | 95%↑ |
| 2017 | 73%↑ |
| 2018 | -28%↓ |
| 2019 | 0%↓ |
| 2020 | 0%↓ |
| 2021 | 9110%↑ |
| 2024 | -83%↓ |
Syndax quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Syndax quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2015 | - | - | - | $305,000 |
| 2016 | $305,000 | $305,000 | $305,000 | $305,000 |
| 2017 | $305,000 | $305,000 | $305,000 | $1.2M |
| 2018 | $379,000 | $379,000 | $379,000 | $379,000 |
| 2019 | $379,000 | $379,000 | $379,000 | $379,000 |
| 2020 | $379,000 | $379,000 | $379,000 | $379,000 |
| 2021 | $379,000 | $379,000 | $12.4M | $126.6M |
| 2024 | - | $3.5M | $12.5M | $7.7M |
Syndax jobs nearby
Do you work at Syndax?
Is Syndax transparent about its revenue structure?
Syndax financing
Syndax received early financing of $40.0M on 2007-04-03.
| Series | Round size | Date |
|---|---|---|
| Series A | $40M | 04/2007 |
| Series A | $9M | 03/2010 |
| Debt Financing | $6M | 04/2010 |
| Series B | $26.6M | 08/2013 |
| Series Unknown | $1.7M | 02/2014 |
| Debt Financing | $4.9M | 09/2014 |
| Series C | $80M | 08/2015 |
| Post Ipo Debt | $30M | 01/2020 |
| Post Ipo Equity | $75.3M | 12/2021 |
Syndax investors
| Investors | Security type |
|---|---|
| Avalon Ventures | Series A |
| Forward Ventures | Series A |
| Pappas Ventures | Series A |
| MPM Capital | Series A |
| Domain Associates | Series A |
| Avalon Ventures | Series A |
| Forward Ventures | Series A |
| Pappas Ventures | Series A |
| MPM Capital | Series A |
| Domain Associates | Series A |
| Forward Ventures | Series B |
| MPM Capital | Series B |
| RMI Partners | Series B |
| Domain Associates | Series B |
| Delos Capital | Series C |
| EcoR1 Capital LLC | Series C |
| PRAKASH CHAINANI MBA (FINANCE) CMA LIFE SCIENCES US CFO | Series C |
| MPM Capital | Series C |
| ArrowMark Partners | Series C |
| FMR Co. | Series C |
| Domain Associates | Series C |
| Jennison Associates | Series C |
| Forward Ventures | Series C |
| Cormorant Asset Management | Series C |
| OrbiMed Advisors | Series C |
| RMI Partners | Series C |
| BioMed Ventures | Series C |
| PRAKASH CHAINANI MBA (FINANCE) CMA LIFE SCIENCES US CFO | Post Ipo Debt |
| Frazier Healthcare Partners | Post Ipo Debt |
| Biotechnology Value Fund | Post Ipo Debt |
| Boxer Capital | Post Ipo Debt |
| HERCULES CAPITAL INC | Post Ipo Debt |
Syndax competitors
Syndax's top competitor, capefearvalley, earned an annual revenue of $1.0B.
Syndax's smallest competitor is Theraclone Sciences with revenue of $470.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Theraclone Sciences | - | $470,000 | 2 | - |
| Otonomy | - | $1.0M | 49 | - |
| Cerexa Inc. | - | $1.3M | 29 | - |
| Good Start Genetics | - | $1.9M | 37 | - |
| American Society of Clinical Oncology | - | $144.5M | 663 | - |
| capefearvalley | - | $1.0B | 7,500 | - |
| Accelovance | - | $39.0M | 50 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Most in demand jobs
Zippia gives an in-depth look into the details of Syndax, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Syndax. The employee data is based on information from people who have self-reported their past or current employments at Syndax. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Syndax. The data presented on this page does not represent the view of Syndax and its employees or that of Zippia.
Syndax may also be known as or be related to SYNDAX PHARMACEUTICALS INC, Syndax, Syndax Pharmaceuticals, Syndax Pharmaceuticals Inc and Syndax Pharmaceuticals, Inc.